Inspiration Healthcare Group PLC European Patent granted for Project WAVE
02 Dicembre 2020 - 8:00AM
RNS Non-Regulatory
TIDMIHC
Inspiration Healthcare Group PLC
02 December 2020
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
European Patent granted for Project WAVE
Inspiration Healthcare Group plc (AIM: IHC), the global medical
technology company, is pleased to announce that "Project WAVE" has
been granted a patent by the European Patent Office and can now be
validated in individual countries within the EU.
"Project WAVE" is a novel technology used in a respiratory
device for neonatal intensive care which was acquired under licence
by Inspiration Healthcare in 2019 from a major US West Coast
University. The project has been granted a patent by the US Patent
Office which was announced on 25 March 2020.
On 16th November 2020 it was announced that the UK Medicines and
Healthcare products Regulatory Agency (MHRA) has cleared project
WAVE for clinical testing which is expected to commence in the new
year at the Trevor Mann Baby Unit, Brighton & Sussex University
Hospital (Royal Sussex).
Neil Campbell, Chief Executive Officer, commented: "As we
continue to move forward in the development of Project WAVE this is
another milestone passed and one which both protects our IP and the
investment we have made to ensure that this technology soon becomes
adopted in hospitals, and we remain confident that once this
happens, we will begin to see improved medical outcomes using this
novel technology."
Enquiries:
Inspiration Healthcare Group plc Tel: 01455 840555
Neil Campbell, Chief Executive Officer
Jon Ballard, Chief Financial Officer
Nominated Adviser & Broker Tel: 0207 397 8900
Cenkos Securities plc
Mark Connelly
Stephen Keys
-------------------
Cadogan PR Tel: 07771 713608
Alex Walters
alex.walters@cadoganpr.com
-------------------
About Inspiration Healthcare http://www.inspiration-healthcare.com
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in critical care & operating
theatres. The Company provides high-quality, innovative products to
patients around the world which help to improve patient outcomes,
and it actively invests in innovative product opportunities and
disruptive technologies.
Through investment in research and development the Company has
six key own-brand products that can be used within the first 6
hours of life to help premature and sick babies; helping with
assessment, resuscitation, stabilisation as well as preventing
brain damage. Additionally, the Company has a range of products for
maintaining normothermia pre- during and post-surgery.
In September 2019, the Company acquired Vio Holdings a designer,
manufacturer and supplier of single-use respiratory products and
sterile medical consumables for GBP4 million and in June 2020 the
Company acquired SLE, a leading global provider of neonatal
ventilation products for GBP18 million. Over 90% of SLE's revenues
are generated from sales outside of the UK with a significant
proportion of these in the Asia Pacific and the Middle East. When
combined, the Group generates approximately 60 per cent. of its
revenue from exports.
With product availability extending to over 50 countries through
a distribution network, Inspiration Healthcare's success has been
built on continuous innovation, excellent customer service and an
inherent commitment to improving patient outcomes, working in close
collaboration with key opinion leaders across the globe.
In the U.K. and Ireland, the Company has a direct sales team
selling Inspiration Healthcare Branded and complementary products
from third parties, with an additional range of home healthcare
products. This is supported by Technical Support for planned
preventative maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUPGWCPUPUGQG
(END) Dow Jones Newswires
December 02, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Inspiration Healthcare (LSE:IHC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Inspiration Healthcare (LSE:IHC)
Storico
Da Apr 2023 a Apr 2024